Skip to main content

Advertisement

Cancer gene mutation discovery and detection using array-based resequencing

Article metrics

We set out to determine the feasibility of using microarray-based resequencing for cancer gene mutation screening by designing GeneChip CustomSeq Resequencing arrays (Affymetrix, Santa Clara, CA, USA) for interrogation of ARAF, BRAF, CDK4, CDK6, CDKN2A, KLF6, HRAS, KRAS, MET, NRAS, PTEN, RAF1, RB1, RET and TP53 (164 exons in total). Arrays also included four intronic bases on either side of the exons to cover splice sites, thus the arrays covered a total of 23,966 bases. Overall performance was very good, with accuracy >99.99% and coverage ~97.5%. Twenty NSCLC samples were analyzed using the arrays, and several well-characterized somatic mutations and germline variants were found. The most significant novel finding was the detection of a transforming MET mutation (T1010I) in a NSCLC patient.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tengs, T., Lee, J., Paez, J. et al. Cancer gene mutation discovery and detection using array-based resequencing. Breast Cancer Res 7, P4.51 (2005) doi:10.1186/bcr1181

Download citation

Keywords

  • Cancer Research
  • Gene Mutation
  • Splice Site
  • Somatic Mutation
  • NSCLC Patient